Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression

Introduction: Although various therapies have been adopted to treat cancer, metastasis of tumor cells still is a big challenge that compromises therapeutic benefits.Methods: We herein report an injectable drug-loaded hybrid hydrogel that can achieve sonodynamic therapy (SDT) and chemodyanmic therapy...

Full description

Bibliographic Details
Main Authors: Xiaoying Wang, Liyun Zhu, Jianhui Zhou, Lingzhou Zhao, Jingchao Li, Changcun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1281157/full
_version_ 1797681797867241472
author Xiaoying Wang
Liyun Zhu
Jianhui Zhou
Lingzhou Zhao
Jingchao Li
Changcun Liu
author_facet Xiaoying Wang
Liyun Zhu
Jianhui Zhou
Lingzhou Zhao
Jingchao Li
Changcun Liu
author_sort Xiaoying Wang
collection DOAJ
description Introduction: Although various therapies have been adopted to treat cancer, metastasis of tumor cells still is a big challenge that compromises therapeutic benefits.Methods: We herein report an injectable drug-loaded hybrid hydrogel that can achieve sonodynamic therapy (SDT) and chemodyanmic therapy (CDT) combined action and suppression of tumor metastasis. This alginate (ALG)-based hydrogel (termed as AMPS) contains manganese dioxide (MnO2) nanoparticles as the CDT agents, an organic polymer as the sonosensitizer, and a SIS3 drug as metastasis inhibitor.Results: AMPS is formed via the chelation of ALG by Ca2+ in tumor microenvironment, in which MnO2 nanoparticles mediate CDT via Fenton-like reaction and the organic polymers enable SDT under ultrasound (US) irradiation by generating singlet oxygen (1O2), allowing for combinational action of CDT and SDT. In addition, SIS3 is released from AMPS hydrogels to inhibit the metastasis of tumor cells. As such, the AMPS enables a combinational action of SDT and CDT to greatly inhibit the growths of subcutaneous tumors in living mice and also completely suppress the tumor metastasis in lungs and livers.Conclusion: This study thus offers a hybrid hydrogel platform for combinational therapy and metastasis suppression simultaneously.
first_indexed 2024-03-11T23:50:14Z
format Article
id doaj.art-7090ccaaed444158aa27a533f3815c30
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-03-11T23:50:14Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-7090ccaaed444158aa27a533f3815c302023-09-19T07:35:48ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-09-011110.3389/fbioe.2023.12811571281157Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppressionXiaoying Wang0Liyun Zhu1Jianhui Zhou2Lingzhou Zhao3Jingchao Li4Changcun Liu5Office of Hospital Infection and Disease Control and Prevention, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaCollege of Biological Science and Medical Engineering, Donghua University, Shanghai, ChinaCollege of Biological Science and Medical Engineering, Donghua University, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaCollege of Biological Science and Medical Engineering, Donghua University, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaIntroduction: Although various therapies have been adopted to treat cancer, metastasis of tumor cells still is a big challenge that compromises therapeutic benefits.Methods: We herein report an injectable drug-loaded hybrid hydrogel that can achieve sonodynamic therapy (SDT) and chemodyanmic therapy (CDT) combined action and suppression of tumor metastasis. This alginate (ALG)-based hydrogel (termed as AMPS) contains manganese dioxide (MnO2) nanoparticles as the CDT agents, an organic polymer as the sonosensitizer, and a SIS3 drug as metastasis inhibitor.Results: AMPS is formed via the chelation of ALG by Ca2+ in tumor microenvironment, in which MnO2 nanoparticles mediate CDT via Fenton-like reaction and the organic polymers enable SDT under ultrasound (US) irradiation by generating singlet oxygen (1O2), allowing for combinational action of CDT and SDT. In addition, SIS3 is released from AMPS hydrogels to inhibit the metastasis of tumor cells. As such, the AMPS enables a combinational action of SDT and CDT to greatly inhibit the growths of subcutaneous tumors in living mice and also completely suppress the tumor metastasis in lungs and livers.Conclusion: This study thus offers a hybrid hydrogel platform for combinational therapy and metastasis suppression simultaneously.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1281157/fullalginate hydrogelsdrug deliverytumor metastasissonodynamic therapychemodyanmic therapy
spellingShingle Xiaoying Wang
Liyun Zhu
Jianhui Zhou
Lingzhou Zhao
Jingchao Li
Changcun Liu
Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression
Frontiers in Bioengineering and Biotechnology
alginate hydrogels
drug delivery
tumor metastasis
sonodynamic therapy
chemodyanmic therapy
title Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression
title_full Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression
title_fullStr Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression
title_full_unstemmed Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression
title_short Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression
title_sort drug loaded hybrid hydrogels for sonodynamic chemodyanmic therapy and tumor metastasis suppression
topic alginate hydrogels
drug delivery
tumor metastasis
sonodynamic therapy
chemodyanmic therapy
url https://www.frontiersin.org/articles/10.3389/fbioe.2023.1281157/full
work_keys_str_mv AT xiaoyingwang drugloadedhybridhydrogelsforsonodynamicchemodyanmictherapyandtumormetastasissuppression
AT liyunzhu drugloadedhybridhydrogelsforsonodynamicchemodyanmictherapyandtumormetastasissuppression
AT jianhuizhou drugloadedhybridhydrogelsforsonodynamicchemodyanmictherapyandtumormetastasissuppression
AT lingzhouzhao drugloadedhybridhydrogelsforsonodynamicchemodyanmictherapyandtumormetastasissuppression
AT jingchaoli drugloadedhybridhydrogelsforsonodynamicchemodyanmictherapyandtumormetastasissuppression
AT changcunliu drugloadedhybridhydrogelsforsonodynamicchemodyanmictherapyandtumormetastasissuppression